17
Apr
2024

Spera Pharma Inc

Exhibitor at CPHI Japan 2024 stand 6C-22
About Us

With passion and exceptional technologies, experts in CMC research support the creation of outstanding and innovative drugs.

SPERA PHARMA was established as a spin-out of Takeda Pharmaceutical Company by Chemistry, Manufacturing and Controls (CMC) research experts, who were already responsible for delivering numerous new drugs to high global acclaim. As a member of the Bushu Pharmaceuticals Group, SPERA PHARMA is responsible for the entire CMC process, from R&D through application; it provides services that meet the needs of customers. As the development of new drugs becomes increas...

  • JP
  • 2017
    On CPHI since
Company types
Contract Service
Contact info
  • 17-85 Jusohonmachi 2 - chome, Yodogawa-ku, 532-0024, Osaka, Japan
Event information
CPHI Japan 2024
  • 17 Apr 2024 – 19 Apr 2024
  • East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
  • Visit us at stand 6C-22

Products Featured at CPHI Japan 2024

  • Cmc R & D Of Pharmaceuticals

    Product Cmc R & D Of Pharmaceuticals

    Spera Pharma, Inc offers cmc r & d of pharmaceuticals. Features: it provide high-level solutions tailored to the needs globally at all stages from r & d to commercial production. It supplies drug substance through optimal and flexible supply chain construction. Formulate design of low molecule compounds an...